Johnson & Johnson $JNJ Shares Purchased by Stonebrook Private Inc.

Stonebrook Private Inc. grew its holdings in Johnson & Johnson (NYSE:JNJ) by 1.7% during the second quarter, HoldingsChannel.com reports. The fund owned 23,461 shares of the company’s stock after purchasing an additional 391 shares during the quarter. Johnson & Johnson makes up about 0.8% of Stonebrook Private Inc.’s portfolio, making the stock its 24th biggest holding. Stonebrook Private Inc.’s holdings in Johnson & Johnson were worth $3,583,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. GFG Capital LLC acquired a new position in Johnson & Johnson in the 2nd quarter worth $35,000. Stone House Investment Management LLC purchased a new position in Johnson & Johnson in the first quarter valued at about $47,000. 1248 Management LLC acquired a new stake in Johnson & Johnson during the 1st quarter valued at approximately $48,000. Harvest Fund Management Co. Ltd purchased a new stake in Johnson & Johnson during the 1st quarter worth approximately $52,000. Finally, Pandora Wealth Inc. acquired a new position in shares of Johnson & Johnson in the 1st quarter valued at approximately $65,000. 69.55% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Johnson & Johnson news, EVP Jennifer L. Taubert sold 56,471 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $177.81, for a total value of $10,041,108.51. Following the completion of the sale, the executive vice president directly owned 178,013 shares of the company’s stock, valued at approximately $31,652,491.53. This represents a 24.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.16% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on JNJ. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $209.00 price target on shares of Johnson & Johnson in a report on Friday, October 10th. Bank of America boosted their target price on shares of Johnson & Johnson from $198.00 to $204.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 15th. Daiwa America raised shares of Johnson & Johnson from a “hold” rating to a “strong-buy” rating in a research report on Monday, October 20th. Weiss Ratings reissued a “buy (b)” rating on shares of Johnson & Johnson in a report on Friday, October 31st. Finally, Cowen reaffirmed a “buy” rating on shares of Johnson & Johnson in a report on Tuesday, October 14th. Four equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $201.05.

Johnson & Johnson Price Performance

Shares of JNJ opened at $200.10 on Wednesday. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $200.30. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80. The stock has a fifty day moving average price of $186.69 and a 200 day moving average price of $170.77. The company has a market cap of $482.11 billion, a P/E ratio of 19.31, a PEG ratio of 2.19 and a beta of 0.38.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share (EPS) for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%.The business had revenue of $24.02 billion during the quarter. On average, research analysts forecast that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 25th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Tuesday, November 25th. Johnson & Johnson’s payout ratio is presently 50.19%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.